Pancreatic Cancer Research

ResearcherNihon UniversityNo recent work listed

Hiroki Nagase

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3992-5399; OpenAlex author ID A5017785312. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 4 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 12

  1. Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/cam4.5359↗
  2. Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer. Last author DOI 10.1371/journal.pone.0268630↗
  3. Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic … Last author DOI 10.3892/ijo.2022.5350↗
  4. Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice. Last author DOI 10.1038/s41598-021-82617-2↗
  5. Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer. Co-author DOI 10.1038/s41416-020-0997-1↗
  6. MIR1246 in body fluids as a biomarker for pancreatic cancer. Co-author DOI 10.1038/s41598-020-65695-6↗
  7. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. Last author DOI 10.1371/journal.pone.0232230↗
  8. Prognostic significance of p16 protein in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/mco.2020.2047↗
  9. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Co-author DOI 10.1038/cddis.2015.242↗
  10. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Co-author DOI 10.1038/cddiscovery.2015.10↗
  11. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2013.10.010↗
  12. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2012.10.048↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yosuke Iwatate · 5 shared papers, 2020–2022 · strength 0.58
  2. Fumitaka Ishige · 5 shared papers, 2020–2022 · strength 0.58
  3. Hidehito Arimitsu · 5 shared papers, 2020–2022 · strength 0.58
  4. Wataru Takayama · 5 shared papers, 2020–2022 · strength 0.58
  5. Yasukuni Mori · 3 shared papers, 2020–2022 · strength 0.36
  6. Miho Akimoto · 2 shared papers, 2020–2021 · strength 0.35
  7. Osamu Shimozato · 4 shared papers, 2015–2022 · strength 0.35
  8. Naoki Kuwayama · 2 shared papers, 2022 · strength 0.25
  9. Takashi Uno · 2 shared papers, 2022 · strength 0.25
  10. Keizo Takenaga · 1 shared paper, 2021 · strength 0.19
  11. Akiko Tsujimoto · 1 shared paper, 2023 · strength 0.17
  12. Keizo Takenaga · 1 shared paper, 2020 · strength 0.16
  13. Hirokazu Sugimoto · 2 shared papers, 2015 · strength 0.10
  14. Mizuyo Nakamura · 2 shared papers, 2015 · strength 0.10
  15. Toshinori Ozaki · 2 shared papers, 2015 · strength 0.10
  16. Makoto Sunamura · 2 shared papers, 2012–2013 · strength 0.06
  17. Yuriko Saiki · 2 shared papers, 2012–2013 · strength 0.06
  18. Shinichi Fukushige · 2 shared papers, 2012–2013 · strength 0.06
  19. Akira Horii · 2 shared papers, 2012–2013 · strength 0.06
  20. Meijie Sang · 1 shared paper, 2015 · strength 0.05
  21. Meixiang Sang · 1 shared paper, 2015 · strength 0.05
  22. Shinichi Egawa · 1 shared paper, 2013 · strength 0.03
  23. Akihiro Yamamura · 1 shared paper, 2013 · strength 0.03
  24. Kazuhiro Morishita · 1 shared paper, 2013 · strength 0.03
  25. Michiaki Unno · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.